Gene Expression Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Instruments is the fastest growing sector, North America is the largest market

The Global Gene Expression Analysis Market is projected to grow from USD 5.52 Billion in 2025 to USD 8.72 Billion by 2031, achieving a Compound Annual Growth Rate (CAGR) of 7.92%. Gene expression analysis involves the quantitative measurement of messenger RNA levels to assess specific gene activity within biological samples, a process essential for elucidating cellular functions and understanding the mechanisms underlying various diseases. This market is primarily supported by the escalating demand for precision medicine and the intensive focus on targeted drug discovery within the pharmaceutical industry. Furthermore, decreasing genomic sequencing costs enable broader adoption for biomarker identification and validation, thereby propelling market growth.

The rising prevalence of chronic conditions, particularly oncology, necessitates robust genomic profiling tools to guide therapeutic decisions, with the American Cancer Society projecting 2,041,910 new cancer cases in the United States in 2025. This substantial disease burden drives the necessity for expression analysis, yet the market faces a significant challenge regarding the interpretation of complex large-scale data. The scarcity of skilled bioinformatics professionals required to analyze these vast datasets serves as a major bottleneck that could impede the full expansion of the Global Gene Expression Analysis Market.

Market Drivers

Technological advancements in Next-Generation Sequencing (NGS) and PCR platforms are fundamentally transforming the Global Gene Expression Analysis Market by improving throughput and simplifying genomic profiling. These innovations empower laboratories to process extensive biological data with remarkable speed and accuracy, thereby accelerating the integration of expression analysis into clinical and research environments. High-performance sequencing devices have been a key driver for market expansion, as demonstrated by leading innovators; Oxford Nanopore Technologies reported 23% underlying revenue growth on a constant currency basis in its 2024 annual results, largely due to new sensing platform adoption, while Illumina recorded full-year 2024 revenue of $4.3 billion, highlighting significant global demand for advanced genomic infrastructure.

Furthermore, robust government funding and private investment in genomic research serve as another critical driver, supplying essential capital for scaling precision medicine initiatives and population health studies. Public sector commitments are crucial for biomarker validation and embedding gene expression profiling into national healthcare systems, mitigating risks in new diagnostic tool development. These investments foster a stable growth environment, ensuring long-term project viability, exemplified by the UK Government's significant £650 million investment by 2030 to advance genomic medicine and expand newborn sequencing, which not only speeds up gene-disease association discovery but also mandates broader use of expression analysis technologies in public health.

Market Challenges

The Global Gene Expression Analysis Market is significantly constrained by a scarcity of skilled bioinformatics professionals. Despite the rapid acceleration in genomic data generation, the ability to process and interpret this vast information has lagged, creating a bottleneck where substantial volumes of expression data remain underutilized. This gap delays the conversion of raw sequencing results into actionable biological insights, hindering pharmaceutical companies and research institutions in efficiently validating biomarkers and thereby slowing drug development and clinical applications.

This shortage of specialized talent elevates operational costs and extends project timelines, as organizations compete for a limited pool of experts capable of managing complex high-throughput expression data analysis. According to the Pistoia Alliance in 2025, 34% of life science professionals identified a lack of skilled personnel as a major impediment to adopting advanced data analysis technologies, thus preventing the market from achieving its full scalability across healthcare and research sectors.

Market Trends

The integration of Artificial Intelligence (AI) and Machine Learning (ML) in data analysis is rapidly enhancing market value by transforming intricate genomic datasets into actionable insights. With the exponential growth of gene expression data, AI-driven platforms are increasingly replacing traditional bioinformatics methods, efficiently identifying novel biomarkers and therapeutic targets. This trend validates a commercial model where advanced data interpretation is as crucial as sequencing, directly addressing the challenge of data complexity, as demonstrated by Tempus AI, Inc. reporting total revenue of $693.4 million in 2024, with 30.4% year-over-year growth primarily from algorithmic data services.

Concurrently, the widespread adoption of spatial transcriptomics for tissue mapping is revolutionizing biological research by enabling the visualization of gene activity within the precise physical architecture of tissues. This method overcomes bulk sequencing limitations by maintaining spatial context, which is vital for understanding complex conditions such as the tumor microenvironment. The market is also seeing a significant increase in specialized hardware installations for these high-resolution studies, establishing a lasting infrastructure for single-cell and spatial biology; 10x Genomics, Inc., for instance, reported over 7,000 cumulative instruments sold by the end of 2024, highlighting the growing penetration of these advanced tools in global laboratories.

Key Market Players

• Merck KGaA
• Genscript Biotech Corporation
• Qiagen N.V.
• Bio-Rad Laboratories Inc.
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Agilent Technologies Inc.
• Lonza Group Ltd.
• New England Biolabs Inc

Report Scope

In this report, the Global Gene Expression Analysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gene Expression Analysis Market, by Product Type:

• Instruments
• Services
• Others

Gene Expression Analysis Market, by Technique:

• RNA Expression
• Promotor Analysis
• Protein Expression & Post Translational Modification Expression
• Others

Gene Expression Analysis Market, by Application:

• Drug Discovery and Development
• Clinical Diagnostics
• Biotechnology and Microbiology
• Others

Gene Expression Analysis Market, by End User:

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic and Government Research Institutes
• Others

Gene Expression Analysis Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gene Expression Analysis Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.